The Australian Clinical Guidelines on HTLV-1 for Aboriginal Primary Health Care Settings (the Guidelines) are a comprehensive, culturally safe and evidence-based guide to the prevention, testing, diagnosis, management and care of Human T-lymphotropic virus subtype 1 (HTLV-1).

These Guidelines were developed by the National Aboriginal Community Controlled Health Organisation (NACCHO), in partnership with the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) in response to community calls for action on HTLV-1. A governance group including NACCHO affiliates and ACCHO representatives and other experts provided oversight to the development of the Guidelines.

While for many years the high prevalence of HTLV-1 in Central Australia has been known, these are the first Guidelines to be developed for primary health care services. These Guidelines are the result of advocacy from the ACCHO sector following a series of workshops, including a 2018 Collaborative Forum hosted by the Australian Government Department of Health and Aged Care. The forum recommended the development of clinical guidelines to promote a coordinated approach to HTLV-1 in Australia.  

The Guidelines are up to date as of March 2025. The Guidelines will be reviewed and updated annually.